LD-2 disclosure · 1st Quarter - Report
ORPHAZYME US, INC.
Income$45Kfee reported
Client
- Name
- ORPHAZYME US, INC.
- Description
- Development of Heat-Shock Protein response for treatment of neurodegenerative rare disease
- Location
- Illinois · United States of America
Registrant
- Description
- lobby firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issueMedical/Disease Research/Clinical Labs
H.R. 1730/S. 670, Speeding Therapy Access Today (STAT) Act H.R. 482/S. 350, Newborn Screening Reauthorization Act
LobbyistsPATROSKI LAWSON · BENJAMIN MASON · KATHERINE LANDES
TargetedSENATE